ProfileGDS4177 / 229899_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 51% 55% 30% 59% 55% 59% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated35.751
GSM603099KU-812 non-treated41.4855
GSM603098KCL-22 Imatinib-treated14.4430
GSM603097KCL-22 non-treated48.8959
GSM603102JURL-MK1 Imatinib-treated40.3755
GSM603101JURL-MK1 non-treated49.5459